Investor profile
Lily Chang
Family Office, Private equity, Venture capital & Principal at Novo Holdings
Lily Chang works as a Principal at Novo Holdings. The firm's known portfolio counts 10 companies.
Is Lily Chang a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Focus
- BiotechDiagnosticsDrug DiscoveryFoundation-backedGenomicsMedTechMedical Devices
Contacts
Affiliated funds' portfolios
Principal at Novo Holdings, whose known portfolio counts 10 companies
- ADCendo
- Ray Therapeutics
- Alveus Therapeutics
- Terremoto Biosciences
- Route 92 Medical
- Coultreon Biopharma
- Reduced
- SUBRA A/S
- Sylvan
- Surya Hospitals
Investor Profile
The listing covers sectors FinTech, Hardware and Healthcare, and focus areas Biotech, Diagnostics, Drug Discovery and Foundation-backed. Startups operating in these areas may find Lily Chang relevant.
Novo Holdings appears in Growth, Late-Stage and Series A rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Lily Chang matches their raise.
Colleagues at Novo Holdings
Showing 20 of 32
Karthik Narayanaswamy
Partner & Head of India
Mumbai, India
Jim Trenkle
Partner, Venture Investments
San Francisco, United States
Joe Markson
Principal
Boston, United States
Scott Beardsley
Managing Partner
San Francisco, United States
Søren Møller
Managing Partner, Novo Seeds
Copenhagen, Denmark
Jean-Luc Butel
Member, Novo Advisory Group
Singapore
Peder Holk Nielsen
Member of Novo Holdings' advisory group
Copenhagen, Denmark
Colby Ye
Principal
Boston, United States
Marie Schroeder
Vice President
Copenhagen, Denmark
Campbell Stewart
Principal
United Kingdom
Emmanuelle Coutanceau
Partner
Copenhagen, Denmark
Max Klement
Partner, Venture Investments
London, United Kingdom
Doheon Koo
Vice President
Singapore
Hongjie Hu
Partner
San Francisco, United States
Simon Burr
Vice President
United Kingdom
Eric Snyder
Partner, Venture Investments
Boston, United States
Heather Ludvigsen
Senior Manager
Copenhagen, Denmark
Noel Jee
Partner
San Francisco, United States
Taj Heer
Investment Director
United Kingdom
Anna Fan
Investor
San Francisco, United States
Frequently asked questions
Who is Lily Chang?
Lily Chang is a family office investor and private equity investor based in San Francisco, California, United States, listed as Principal at Novo Holdings. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Lily Chang personally.
What does Lily Chang invest in?
Listed sectors include FinTech, Hardware and Healthcare; listed focus areas include Biotech, Diagnostics, Drug Discovery and Foundation-backed. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Lily Chang invest at?
Novo Holdings appears in Growth, Late-Stage and Series A rounds across its known deals, and Lily Chang is listed there as Principal. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Lily Chang listed at?
Lily Chang is listed as Principal at Novo Holdings. 32 other people in the database share a firm with Lily Chang.
How do I contact Lily Chang?
A phone number and a LinkedIn page are on file for Lily Chang. They are readable inside RaiseHunt after you create an account. The database holds no email address for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal